Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
PLoS One ; 11(1): e0147081, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-26785407

RESUMEN

BACKGROUND: Sickle cell disease (SCD) is a major health burden in India. The objective of the study was to establish a neonatal screening program and to understand the clinical course of children with SCD in central India. METHODS AND FINDINGS: Pregnant mothers were screened for sickle hemoglobin using the solubility test. Babies were screened by high performance liquid chromatography if the mother was positive for sickle hemoglobin. The diagnosis was confirmed by molecular analysis. They received early prophylactic treatment and vaccination. Of 2134 newborns screened, 104 were sickle homozygous (SS), seven had sickle ß-thalassemia (S-ß thal) and 978 were sickle heterozygous (AS). The other hemoglobin abnormalities detected included HbS-뫧 thalassemia-1, HbSD disease-2, HbE traits-5, ß-thalassemia traits-4, alpha chain variants-3 and HbH disease-1.These babies were followed up regularly for hematological and clinical evaluation. Pain, severe anemia requiring blood transfusions and acute febrile illness were the major complications with 59.7, 45.1 and 42.6 cases per 100 person years. Fetal hemoglobin (HbF) levels were inversely associated with vaso-oclussive crisis (VOC) and severe anemia while presence of alpha thalassemia increased the rate of painful events and sepsis. Six early deaths occurred among the SS babies. CONCLUSION: A systematic follow up of this first newborn SCD cohort in central India showed that 47% of babies presented within 1 year of age. In spite of the presence of the Arab-Indian haplotype many babies had severe manifestations.


Asunto(s)
Anemia de Células Falciformes/diagnóstico , Anemia de Células Falciformes/tratamiento farmacológico , Hidroxiurea/uso terapéutico , Tamizaje Neonatal , Anemia de Células Falciformes/epidemiología , Anemia de Células Falciformes/mortalidad , Antidrepanocíticos/uso terapéutico , Preescolar , Femenino , Heterocigoto , Homocigoto , Humanos , India/epidemiología , Lactante , Recién Nacido , Masculino , Fenotipo , Embarazo , Tasa de Supervivencia , Resultado del Tratamiento
2.
Clin Chem Lab Med ; 52(12): 1791-6, 2014 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-24978900

RESUMEN

BACKGROUND: Sickle cell disease is a major health burden in India. The aim of the study was to compare the diagnostic utility of two different approaches on automated high performance liquid chromatography (HPLC) for newborn screening for sickle cell disorders and other haemoglobinopathies in India. METHODS: Newborn babies of sickle heterozygous mothers were tested by HPLC using two different kits, the ß-thal short kit, which is routinely used for screening for haemoglobinopathies in most laboratories, and the sickle cell short kit which is specific only for neonatal samples. Confirmation of the sickle and α genotypes was done by molecular analysis. RESULTS: Of the 601 babies tested, 276 were normal, 284 were sickle heterozygous and 41 were sickle homozygous using the ß-thal short kit. Using the sickle cell short kit, a discrepancy was seen in one newborn sample where a normal baby was identified as a sickle heterozygous baby. α-Genotyping was done in 42 babies and 16 of them had α gene deletions. The presence of α thalassaemia could be suspected in 15 of these 16 babies based on a spike at the start of the chromatogram using the ß-thal short kit. In comparison, using the sickle cell short kit the diagnosis of α thalassaemia was difficult based on the percentage of the FAST peak. Further, other rare α chain Hb variants were also missed. CONCLUSIONS: The ß-thal short kit was more versatile than the sickle cell short kit for screening for haemoglobinopathies in newborns in our population.


Asunto(s)
Cromatografía Líquida de Alta Presión , Hemoglobina Falciforme/análisis , Hemoglobinopatías/diagnóstico , Genotipo , Hemoglobina Falciforme/genética , Heterocigoto , Homocigoto , Humanos , Recién Nacido , Tamizaje Neonatal
3.
Indian Pediatr ; 50(8): 787-9, 2013 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-23585421

RESUMEN

We conducted this case-control study in children (age 3-59 mo) to study the risk factors for failure of standard treatment in severe and very severe community acquired pneumonia. One hundred and eighty one children were enrolled in the study among whom 31 (20.4%) had treatment failure. The independent risk factors for treatment failure by 48 hours using multivariate analysis were: infancy, measles immunization not given by 9 months, severe malnutrition, very fast breathing at baseline, hypoxemia at baseline, and bacteremia.


Asunto(s)
Infecciones Comunitarias Adquiridas/terapia , Neumonía/terapia , Preescolar , Hospitalización , Humanos , Lactante , Análisis Multivariante , Factores de Riesgo , Insuficiencia del Tratamiento
4.
Hemoglobin ; 36(4): 316-22, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22712682

RESUMEN

There is limited data on the incidence of sickle cell anemia in Central India; we therefore conducted a study to estimate the incidence of this disease in Central India. Mothers who delivered a live baby at the Government Medical College, Nagpur, India were screened for the presence of the sickle cell hemoglobin {Hb S: [ß6 (A3) Glu→Val, GAG>GTG]} using the solubility test within 48 hours of delivery. Infants of mothers who showed the presence of Hb S then underwent Hb analysis by high performance liquid chromatography (HPLC). A total of 8243 mothers was screened, 1178 of whom were positive. One thousand, one hundred and sixty-two infants of mothers with a positive solubility test underwent Hb analysis by HPLC; 530 infants were normal, while 536 were heterozygous for Hb S (sickle cell trait), 88 babies were homozygous for Hb S (sickle cell anemia), while another eight babies had other Hb abnormalities. The incidence of sickle cell anemia was highest in the Scheduled caste group (1:50). We concluded that the incidence of sickle cell anemia is high in central India.


Asunto(s)
Anemia de Células Falciformes/genética , Pruebas Genéticas/métodos , Hemoglobina Falciforme/genética , Tamizaje Neonatal/métodos , Anemia de Células Falciformes/diagnóstico , Anemia de Células Falciformes/epidemiología , Cromatografía Líquida de Alta Presión , Genotipo , Hemoglobina Falciforme/análisis , Humanos , Incidencia , India/epidemiología , Recién Nacido
5.
Hemoglobin ; 36(4): 323-32, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22734586

RESUMEN

There is limited data on the efficacy of hydroxyurea (HU) in Indian sickle cell anemia patients who have severe manifestations despite high fetal hemoglobin (Hb F). Sixty sickle cell anemia children (5-18 years) with more than three episodes of vasoocclusive crises or blood transfusions per year were randomized to receive HU (n = 30) or placebo (n = 30) therapy. Fixed dose (10 mg/kg/day) of HU was administered for 18 months and the patients were followed-up monthly with clinical assessment and laboratory monitoring. In the HU group, hemoglobin (Hb) and Hb F levels increased significantly along with a significant decrease in the number of painful crises, blood transfusion requirements and hospitalizations compared to the placebo group. No major adverse events were observed in this study. In conclusion, low-fixed dose HU therapy was effective for the treatment of Indian sickle cell anemia children. However, there is a need for long-term studies to evaluate the efficacy and toxicity in a larger number of Indian sickle cell anemia patients.


Asunto(s)
Anemia de Células Falciformes/tratamiento farmacológico , Antidrepanocíticos/uso terapéutico , Hidroxiurea/uso terapéutico , Adolescente , Anemia de Células Falciformes/sangre , Antidrepanocíticos/efectos adversos , Transfusión Sanguínea/estadística & datos numéricos , Niño , Femenino , Hemoglobina Fetal/metabolismo , Estudios de Seguimiento , Hospitalización/estadística & datos numéricos , Humanos , Hidroxiurea/efectos adversos , Masculino , Dolor/prevención & control , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...